| For: | Wang W, Deng ZF, Wang JL, Zhang L, Bao L, Xu BH, Zhu H, Guo Y, Wen Z. Change of tumor-infiltrating lymphocyte of associating liver partition and portal vein ligation for staged hepatectomy for hepatocellular carcinoma. World J Gastrointest Surg 2022; 14(9): 1008-1025 [PMID: 36185571 DOI: 10.4240/wjgs.v14.i9.1008] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i9/1008.htm |
| Number | Citing Articles |
| 1 |
Lingzhen Hu, Zongren Wang, Yang Liao, Xiaomeng Jiang, Huojun Lian, Zhuoying Lin. Tumor-infiltrating T-Lymphocyte immunity-related immune tolerance and anti–programmed cell death protein 1/ligand of programmed cell death protein 1 therapy for advanced hepatocellular carcinoma. Oncology and Translational Medicine 2024; 10(4) doi: 10.1097/ot9.0000000000000041
|
| 2 |
Wenfeng Zhu, Haoqi Chen, Wenjie Zheng, Xiaolong Chen, Li Wang, Xuejiao Li, Hua Li, Yang Yang, Shuguang Zhu, Xiaowen Wang, Genshu Wang. Nutritional Risk Predicts Hepatic Regeneration After Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy in HBV-related HCC. Archives of Medical Research 2026; 57(6) doi: 10.1016/j.arcmed.2026.103446
|
| 3 |
Victor Lopez-Lopez, Carlos Martínez-Caceres, Paula Gomez-Valles, Juan Cruz, Albert Caballero-Illanes, Roberto Brusadin, Asuncion López-Conesa, María Pérez, Kohei Miura, Jesús de la Peña-Moral, Ricardo Robles-Campos. Impact of rapid hypertrophy of tourniquet associating liver partition and portal vein ligation in the tumor progression pathways compared to two stage hepatectomy in patients with colorectal liver metastases. HPB 2023; 25(10) doi: 10.1016/j.hpb.2023.06.005
|